Editorial & Columns Prescription for Segment Reporting by Pharmaceutical Companies in India April 13, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Private Equity and Indian Pharmaceutical Industry- A Review March 7, 2024 | Dr. Anil Kumar Angrish | No Comments | More